CARE Ratings Limited has announced a scheduled analyst and institutional investor meeting set for March 26, 2026, as part of its regular investor engagement activities. The company informed both BSE and NSE about this meeting under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The investor meeting has been organized by Nuvama Institutional Equities and will feature participation from TenCore Partners as the fund/research house. The meeting is scheduled as an in-person event, providing direct interaction between the company's management and institutional stakeholders.

Regulatory Compliance and Documentation

The company has fulfilled its disclosure obligations by notifying both major stock exchanges about the scheduled meeting. CARE Ratings trades on BSE under scrip code 534804 and on NSE under the symbol CARERATING. The notification was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, on March 23, 2026.

Investor Presentation Availability

CARE Ratings has made its Q3FY26 investor presentation publicly available on the company website ahead of the meeting. The presentation document is accessible through the company's official portal, ensuring transparency and providing participants with comprehensive financial and operational information.

Meeting Framework

The company has clarified that all discussions during the analyst meet will be based exclusively on publicly available information, maintaining compliance with disclosure regulations. CARE Ratings has also noted that the meeting schedule may be subject to changes due to exigencies on the part of either the investor or the company, providing flexibility for both parties involved in the engagement process.

CARE Ratings Limited has formally announced an analyst and institutional investor meeting scheduled for March 25, 2026, in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company communicated this development to both BSE Limited and The National Stock Exchange of India Ltd. on March 20, 2026.

Meeting Details

The scheduled investor engagement presents the following specifics:

Regulatory Compliance and Documentation

The company has emphasized that all discussions during the meeting will be based exclusively on publicly available information, ensuring transparency and regulatory compliance. CARE Ratings has proactively made the investor presentation available on its official website, specifically the Q3FY26 presentation document.

The company has also noted that the meeting schedule may undergo changes due to exigencies on the part of either the investor or the company, providing flexibility for both parties involved.

Corporate Communication

The formal intimation was signed by Manoj Kumar CV, Company Secretary & Compliance Officer of CARE Ratings Limited, and was digitally executed on March 20, 2026. This structured approach to investor relations demonstrates the company's commitment to maintaining transparent communication with its stakeholder community while adhering to prescribed regulatory frameworks.